![]() |
![]() |
||
Prevention Strategy Memory and The Brain Alzheimer's Disease Resources About Us
|
|||
Prevention Through Delay |
Contrary to a general belief that AD treatment does not work, currently available mediations for Alzheimer's disease (AD) are beneficial and, in many cases, delay disease progression for 2 to 4.5 years. Combining these pharmacologic treatments with other types of treatments brings the maximum benefits to the patients. Other types of treatment include:
Today there are five FDA-approved medications for treatment of AD (e.g. Cognex (tacrine), Aricept (donepezil), Razzadyne (galantamine), Exelon (rivastigmine) and Namenda (memantine)) and all of them have shown positive treatment outcomes in long-term studies. Cholinesterase Inhibitors Cholinesterase inhibitors also appear to slow the production of beta amyloid (the primary cause of AD), which delays AD progression. Glutamate Receptor Modulators
|
Home | Prevention Strategy | Memory and The Brain | Alzheimer's Disease | Resources | About Us
Privacy Policy | Terms of Use PreventAD.com is sponsored by Medical Care Corporation, a provider of advanced neuroinformatics technoogies. |